v3.22.2.2
Stockholders' Equity (Narrative) (Details)
$ / shares in Units, $ in Millions
1 Months Ended
Jun. 24, 2022
Nov. 23, 2021
shares
Jan. 22, 2020
shares
Jun. 30, 2022
Nov. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2022
vote
shares
Dec. 31, 2021
shares
Subsidiary, Sale of Stock [Line Items]              
Common stock, shares outstanding (in shares)           16,840,261 14,597,118
Common stock voting rights votes | vote           1  
Reverse stock split ratio 0.1            
Total common shares reserved for future issuance (in shares)           13,884,000  
2021 Closing              
Subsidiary, Sale of Stock [Line Items]              
Share sold (in shares)         5,892,335    
Sale of stock price (in usd per share) | $ / shares         $ 3.60    
Consideration received | $         $ 34.6    
Shares issued upon conversion (in shares)         1    
Class A-4 Convertible Preferred Stock | 2021 Closing              
Subsidiary, Sale of Stock [Line Items]              
Sale of stock price (in usd per share) | $ / shares         $ 3.60    
Nonvoting convertible preferred stock issued (in shares)         372,572    
Directors, Executive Officers and Employees | 2021 Closing              
Subsidiary, Sale of Stock [Line Items]              
Share sold (in shares)         222,222    
Directors, Executive Officers and Employees | Class A-4 Convertible Preferred Stock | 2021 Closing              
Subsidiary, Sale of Stock [Line Items]              
Proceeds from issuance of right to purchase common shares | $         $ 0.8    
2019 Plan              
Subsidiary, Sale of Stock [Line Items]              
Number of additional shares authorized (in shares)     416,686        
Number of years for increase of authorized shares     10 years        
Number of additional shares authorized yearly increase (as a percent)     5.00%        
Common stock available for future grant (in shares)           365,628  
Total common shares reserved for future issuance (in shares)           1,470,768  
Inducement Plan              
Subsidiary, Sale of Stock [Line Items]              
Common stock available for future grant (in shares)           160,000  
Total common shares reserved for future issuance (in shares)   200,000       40,000  
Vesting period   4 years          
Inducement Plan | Share-based Payment Arrangement, Tranche One              
Subsidiary, Sale of Stock [Line Items]              
Award vesting percentage   25.00%          
Inducement Plan | Share-based Payment Arrangement, Tranche Two              
Subsidiary, Sale of Stock [Line Items]              
Vesting period for remaining vesting rights   36 months          
Employee Stock Purchase Plan Two Thousand Twelve | 2022 Employee Stock Purchase Plan              
Subsidiary, Sale of Stock [Line Items]              
Share-based compensation arrangement by share-based payment award, discount from market price, purchase date       15.00%      
Share-based compensation arrangement by share-based payment award, purchase price of common stock, percent       85.00%      
Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)           129,107